| Monkeypox |
0 |
1 |
| Europe |
0 |
0.52 |
| Smallpox |
0 |
0.41 |
| Patient Safety |
0 |
0.34 |
| Pneumonia |
0 |
0.34 |
| Vaccines |
0 |
0.32 |
| Face |
0 |
0.23 |
| Toxicology |
0 |
0.18 |
| Antiviral Agents |
0 |
0.17 |
| Cornea and External Disease |
0 |
0.17 |
| Skin and Soft Tissue Infection |
0 |
0.17 |
| Pain Management |
0 |
0.15 |
| Pregnancy |
0 |
0.14 |
| Child |
0 |
0.12 |
| Food Contamination |
0 |
0.12 |
| Immunization |
0 |
0.12 |
| Prophylaxis |
0 |
0.12 |
| Skin Lesion |
0 |
0.12 |
| Bacterial Skin Infection |
0 |
0.1 |
| Bone Marrow |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Antihistamine |
0 |
0.06 |
| Bacteria |
0 |
0.06 |
| Blister |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Bone |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Conjunctivitis |
0 |
0.06 |
| Dehydration |
0 |
0.06 |
| Depression |
0 |
0.06 |
| Disaster Medicine |
0 |
0.06 |
| Encephalitis |
0 |
0.06 |
| Epidemic |
0 |
0.06 |
| Fatigue |
0 |
0.06 |
| Fever |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Headache |
0 |
0.06 |
| Isolation |
0 |
0.06 |
| Keratitis |
0 |
0.06 |
| Lymph Node |
0 |
0.06 |
| Myalgia |
0 |
0.06 |
| Nephrotoxicity |
0 |
0.06 |
| Outbreak |
0 |
0.06 |
| Palmar |
0 |
0.06 |
| Pedal |
0 |
0.06 |
| Personal Protective Equipment |
0 |
0.06 |
| Scar |
0 |
0.06 |
| Spain |
0 |
0.06 |
| Vaccinia |
0 |
0.06 |
| Varicella-Zoster Virus |
0 |
0.06 |